{"id":536191,"date":"2021-09-09T07:33:55","date_gmt":"2021-09-09T11:33:55","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/"},"modified":"2021-09-09T07:33:55","modified_gmt":"2021-09-09T11:33:55","slug":"enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/","title":{"rendered":"Enveric Biosciences Announces MagicMed Industries’ Presentations at the Following Investor Conferences in September"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n NAPLES, Fla.<\/span>
\n <\/b>, Sept. 9, 2021<\/span> \/PRNewswire\/ —\u00a0Enveric Biosciences<\/a>\u00a0(NASDAQ:\u00a0ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that Dr. Joseph Tucker,\u00a0MagicMed<\/a> Industries’ (“MagicMed”) Chief Executive Officer, is scheduled to present at the H.C. Wainwright 23rd<\/sup> Annual Global Investment Conference and Virtual Gravitas Health Reimagined Investor Day. <\/p>\n

Dr. Tucker’s H.C. Wainwright 23rd<\/sup> Annual Global Investment Conference presentation will be available on-demand beginning Monday, September 13<\/span>th<\/sup> at 7:00 a.m. ET<\/span>. To attend please register here<\/a>.<\/p>\n

Dr. Tucker is also scheduled to present on Thursday, September 16<\/span>th<\/sup> at 10:00 a.m. PT<\/span> \/ 1:00 p.m. ET<\/span> at the Virtual Gravitas Health Reimagined Investor Day. To register for the event please use the following LINK<\/a>.<\/p>\n

On May 24, 2021<\/span>, Enveric Biosciences announced the definitive agreement<\/a>\u00a0to acquire MagicMed Industries. Enveric and MagicMed will each hold a meeting of their respective stockholders. The Enveric annual meeting will be held virtually on September 14, 2021<\/span> at 10:00 a.m., Eastern Time<\/span>, at www.virtualshareholdermeeting.com\/ENVB2021<\/a>.<\/p>\n

For more information about each conference or to schedule a one-on-one meeting with MagicMed’s management team, please contact your appropriate H.C. Wainwright or Gravitas representative directly, or KCSA Strategic Communications at EnvericBio@kcsa.com<\/a>. <\/p>\n

\n About the H.C. Wainwright 23rd<\/sup> Annual Global Investment Conference<\/b>\n <\/p>\n

H.C. Wainwright & Co. is hosting its 23rd Annual Global Investment Conference, which is being held as a virtual event from September 13-15, 2021<\/span>. A record-setting number of participants are expected to view the 850+ company presentations scheduled as live feed or available as recorded for this year’s edition of the H.C. Wainwright Global Investment Conference.<\/p>\n

The conference offers six sector tracks devoted to Healthcare & Biotech, Metals & Mining, Cryptocurrency, Blockchain & FinTech, CleanTech, Technology, Media & Telecommunications and Shipping & Maritime.<\/p>\n

The daily format includes corporate presentations, investor one-on-one meetings, topical presentations by keynote speakers and virtual evening events to encourage informal interaction amongst conference participants. The annual conference is a “must see” event for institutional investors of all types, private equity firms, venture capitalists, industry executives and business development executives.<\/p>\n

\n About the Gravitas Health Reimagined Investor Day
<\/b>This year’s Gravitas Health Reimagined Investor Day will feature several leaders in the healthcare space and will be attended virtually by institutional and retail investors from North America<\/span> and abroad. For additional details about the conference and Gravitas Securities Inc., please visit: www.gravitassecurities.com<\/a><\/p>\n

\n About Enveric Biosciences
<\/b>Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines to improve quality of life for cancer patients. Initial indications include radiodermatitis, a common and often severe side effect of radiation therapy, and chemotherapy-induced neuropathy. For more information, please visit https:\/\/www.enveric.com\/<\/a>.<\/p>\n

\n About MagicMed
<\/b>MagicMed Industries intends to partner with pharmaceutical and other companies to develop and commercialize psychedelic-derived pharmaceutical candidates. MagicMed’s psychedelic derivatives library, the Psybrary\u2122, is anticipated to be an essential building block from which industry can develop new patented products. The initial focus of the Psybrary\u2122 is on psilocybin and DMT derivatives, and it is then expected to be expanded to other psychedelics such as MDMA, LSD, mescaline, and ibogaine. For more information, please\u00a0visit\u00a0https:\/\/www.magicmedindustries.com\/<\/a>.<\/p>\n

\n Investor Contacts
<\/b>
\n Valter Pinto<\/span> \/ Allison Soss
KCSA Strategic Communications
212.896.1254 \/ 212.896.1267
valter@kcsa.com<\/a>\u00a0\/ asoss@kcsa.com<\/a>\u00a0<\/p>\n

\n Media Contacts
<\/b>
\n Caitlin Kasunich<\/span> \/ Raquel Cona<\/span>
KCSA Strategic Communications
212.896.1241 \/ 212.896.1204
ckasunich@kcsa.com<\/a>\u00a0\/ rcona@kcsa.com<\/a>\u00a0<\/p>\n

\n MagicMed Industries Contact<\/b>
\n
\n
\n <\/b>
\n Natalie Dolphin<\/span>
\n
Director of Marketing
ndolphin@magicmedindustries.com<\/a><\/p>\n

\n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september-301371997.html<\/a><\/p>\n

SOURCE Enveric Biosciences<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire NAPLES, Fla. , Sept. 9, 2021 \/PRNewswire\/ —\u00a0Enveric Biosciences\u00a0(NASDAQ:\u00a0ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that Dr. Joseph Tucker,\u00a0MagicMed Industries’ (“MagicMed”) Chief Executive Officer, is scheduled to present at the H.C. Wainwright 23rd Annual Global Investment Conference and Virtual Gravitas Health Reimagined Investor Day. Dr. Tucker’s H.C. Wainwright 23rd Annual Global Investment Conference presentation will be available on-demand beginning Monday, September 13th at 7:00 a.m. ET. To attend please register here. Dr. Tucker is also scheduled to present on Thursday, September 16th at 10:00 a.m. PT \/ 1:00 p.m. ET at the Virtual Gravitas Health Reimagined Investor Day. To register for the … <\/p>\n

Continue reading “Enveric Biosciences Announces MagicMed Industries’ Presentations at the Following Investor Conferences in September”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-536191","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEnveric Biosciences Announces MagicMed Industries' Presentations at the Following Investor Conferences in September - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Enveric Biosciences Announces MagicMed Industries' Presentations at the Following Investor Conferences in September - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NAPLES, Fla. , Sept. 9, 2021 \/PRNewswire\/ —\u00a0Enveric Biosciences\u00a0(NASDAQ:\u00a0ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that Dr. Joseph Tucker,\u00a0MagicMed Industries’ (“MagicMed”) Chief Executive Officer, is scheduled to present at the H.C. Wainwright 23rd Annual Global Investment Conference and Virtual Gravitas Health Reimagined Investor Day. Dr. Tucker’s H.C. Wainwright 23rd Annual Global Investment Conference presentation will be available on-demand beginning Monday, September 13th at 7:00 a.m. ET. To attend please register here. Dr. Tucker is also scheduled to present on Thursday, September 16th at 10:00 a.m. PT \/ 1:00 p.m. ET at the Virtual Gravitas Health Reimagined Investor Day. To register for the … Continue reading "Enveric Biosciences Announces MagicMed Industries’ Presentations at the Following Investor Conferences in September"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-09T11:33:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY00422&sd=2021-09-09\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Enveric Biosciences Announces MagicMed Industries’ Presentations at the Following Investor Conferences in September\",\"datePublished\":\"2021-09-09T11:33:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\\\/\"},\"wordCount\":598,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY00422&sd=2021-09-09\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\\\/\",\"name\":\"Enveric Biosciences Announces MagicMed Industries' Presentations at the Following Investor Conferences in September - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY00422&sd=2021-09-09\",\"datePublished\":\"2021-09-09T11:33:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY00422&sd=2021-09-09\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY00422&sd=2021-09-09\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Enveric Biosciences Announces MagicMed Industries’ Presentations at the Following Investor Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enveric Biosciences Announces MagicMed Industries' Presentations at the Following Investor Conferences in September - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/","og_locale":"en_US","og_type":"article","og_title":"Enveric Biosciences Announces MagicMed Industries' Presentations at the Following Investor Conferences in September - Market Newsdesk","og_description":"PR Newswire NAPLES, Fla. , Sept. 9, 2021 \/PRNewswire\/ —\u00a0Enveric Biosciences\u00a0(NASDAQ:\u00a0ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that Dr. Joseph Tucker,\u00a0MagicMed Industries’ (“MagicMed”) Chief Executive Officer, is scheduled to present at the H.C. Wainwright 23rd Annual Global Investment Conference and Virtual Gravitas Health Reimagined Investor Day. Dr. Tucker’s H.C. Wainwright 23rd Annual Global Investment Conference presentation will be available on-demand beginning Monday, September 13th at 7:00 a.m. ET. To attend please register here. Dr. Tucker is also scheduled to present on Thursday, September 16th at 10:00 a.m. PT \/ 1:00 p.m. ET at the Virtual Gravitas Health Reimagined Investor Day. To register for the … Continue reading \"Enveric Biosciences Announces MagicMed Industries’ Presentations at the Following Investor Conferences in September\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-09T11:33:55+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY00422&sd=2021-09-09","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Enveric Biosciences Announces MagicMed Industries’ Presentations at the Following Investor Conferences in September","datePublished":"2021-09-09T11:33:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/"},"wordCount":598,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY00422&sd=2021-09-09","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/","name":"Enveric Biosciences Announces MagicMed Industries' Presentations at the Following Investor Conferences in September - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY00422&sd=2021-09-09","datePublished":"2021-09-09T11:33:55+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY00422&sd=2021-09-09","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY00422&sd=2021-09-09"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Enveric Biosciences Announces MagicMed Industries’ Presentations at the Following Investor Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/536191","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=536191"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/536191\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=536191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=536191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=536191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}